Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	2 Months Ended	4 Months Ended	6 Months Ended
	Jun. 30, 2021	Apr. 23, 2021	Jun. 30, 2022
Operating activities:
Net loss	$ (47,293)	$ (1,961,989)	$ (56,283)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	18,735	92,758	52,645
Loss on impairment of assets	0	197,027	0
Reorganization items, net		1,587,392
Gain on disposition of assets	(176)	(5,486)	(4,729)
Deferred tax provision	9,952	(35,894)	(1,975)
Stock-based compensation expense	1,134		12,658
Contract liabilities, net	23,572	10,617	(20,870)
Contract assets, net	(509)	(742)	(3,348)
Deferred contract costs, net	(14,987)	(12,034)	(3,859)
Collateral deposits			17,464
Other assets, noncurrent	(1,426)	2,685	(443)
Other liabilities, noncurrent	458	(371)	428
Other	654	3,158	842
Changes in operating assets and liabilities:
Accounts receivable	(53,759)	2,108	(5,039)
Prepaid expenses and other current assets	(26)	(2,791)	(9,417)
Accounts payable and accrued liabilities	(9,972)	29,302	28,832
Taxes payable	7,604	(5,804)	(17,711)
Net cash used in operating activities	(66,039)	(100,064)	(10,805)
Investing activities:
Capital expenditures	(23,973)	(49,119)	(32,353)
Proceeds from disposition of assets, net of disposal costs	193	7,484	5,788
Net cash used in investing activities	(23,780)	(41,635)	(26,565)
Financing activities:
Repayment of borrowings under revolving credit facility		(442,034)
Proceeds from exit facilities	30,000	200,000	40,000
Issuance of exit notes		75,000
Principal payments of finance lease liabilities	(2,240)		(7,735)
Debt issuance costs and arrangement fees		(6,218)
Net cash provided by (used in) financing activities	27,760	(173,252)	32,265
Net change in cash, cash equivalents and restricted cash	(62,059)	(314,951)	(5,105)
Cash, cash equivalents and restricted cash, beginning of period	115,429	430,380	62,729
Cash, cash equivalents and restricted cash, end of period	$ 53,370	$ 115,429	$ 57,624